Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"
2018-12-06 18:12
WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland
2018-12-05 23:29
WuXi Biologics Selected as Forbes Asia's Best Under A Billion 2018
2018-11-29 21:28
WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies
2018-11-28 19:44
WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai
2018-11-22 14:31
WuXi Biologics' Chief Executive Officer Dr. Chris Chen to Serve on Board of Directors at ISPE and Delivered Keynote Speech at 2018 Annual Meeting
2018-11-07 17:51
WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang
2018-10-31 16:08
WuXi Biologics Congratulates Tychan on Completing Human Safety Studies for the First-in-Class Zika Virus Antibody in Record Speed
2018-10-29 20:10
CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics
2018-10-23 20:00
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs
2018-09-26 19:24
WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board
2018-09-25 08:00
WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board
2018-09-25 08:00
WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA
2018-09-18 08:08
WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing
2018-09-11 08:38
WuXi Biologics Selected into the Hang Seng HK 35 Index
2018-08-30 10:08
WuXi Biologics Reports Robust 2018 Interim Results
2018-08-20 20:25
WuXi Biologics Commenced Process Validation in MFG2
2018-07-31 07:55
WuXi Biologics Announced Successful Completion of the First cGMP Run in MFG3
2018-07-25 07:55
WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody
2018-07-09 22:00
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership
2018-06-25 07:55
1
5
6
7
8
9